ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Lamotrigine

Also written as “lamotrigine”, “Lamotrigine Tablets 25 mg” and “Lamictal”.

Its studies are mostly in Epilepsy · Bipolar Disorder · Epilepsy, Tonic-Clonic · Epilepsies, Partial · Schizophrenia, led by 9 companies.

Drug pageLamotrigine: every studyMany companies study it; this page follows only the 54 they lead. All 137 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Aug 14, 200254 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
GlaxoSmithKline330 open or runningphase 4since Aug 14, 2002Aug 14, 2002none ahead
Dr. Reddy's Laboratoriesits history only80 open or runningphase 1since May 26, 2010May 26, 2010none ahead
Teva Pharmaceutical Industriesits history only40 open or runningphase 1since Jan 30, 2009Jan 30, 2009none ahead
IPCA Laboratoriesits history only20 open or runningphase 1since Jun 11, 2012Jun 11, 2012none ahead
Torrent Pharmaceuticalsits history only20 open or runningphase 1since Jul 13, 2009Jul 13, 2009none ahead
Viatrisits history only20 open or runningphase 1since Mar 30, 2008Mar 30, 2008none ahead
Alembic Pharmaceuticalsits history only10 open or runningphase 1since Jan 9, 2018Jan 9, 2018none ahead
Desitin Arzneimittelits history only10 open or runningphase 1since Dec 12, 2023Dec 12, 2023none ahead
Pharmtechnologyits history only10 open or runningphase 1since Mar 29, 2019Mar 29, 2019none ahead

Also a collaborator on its studies: BioPharma Services.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of GlaxoSmithKline only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 18 studies since Aug 14, 2002.

  1. Aug 13, 2007Phase 3 study in EpilepsyNCT00516139 · 122 enrolled · United States
  2. Oct 26, 2007Phase 3 study in Bipolar DisorderNCT00550407 · 215 enrolled · Japan
  3. Nov 28, 2007Phase 3 study in Bipolar DisorderNCT00566020 · 92 enrolled · Japan
  4. Dec 20, 2007Phase 3 study in Mood DisordersNCT00579982 · 97 enrolled · United States
  5. Jan 18, 2008Phase 1 study in EpilepsyNCT00605371 · 209 enrolled · United States
  6. Feb 20, 2008Phase 1 study in EpilepsyNCT00627575 · 119 enrolled · United States
  7. Jul 24, 2008Phase 3 study in Bipolar DisorderNCT00723450 · 301 enrolled · United States
  8. May 12, 2011Phase 1 study in EpilepsyNCT01357902 · 24 enrolled · Hong Kong
  9. Sep 1, 20112 phase 3 studies in EpilepsyNCT01431976, NCT01431963
  10. May 17, 2012Phase 3 study in Bipolar DisorderNCT01602510 · 265 enrolled · China
  11. Jun 13, 2013Phase 1 study in EpilepsyNCT01879423 · 24 enrolled · China
  12. Feb 13, 2014Phase 1 study in EpilepsyNCT02064465 · 138 enrolled · China
  13. Mar 27, 2014Phase 4 study in EpilepsyNCT02100644 · 33 enrolled · Japan
  14. Jul 30, 2015Phase 1 study in Bipolar DisorderNCT02513654 · 16 enrolled · China

TargetBeta

“Sodium channel alpha subunit blocker”ChEMBL 37, by rule

Other programs on the same 10 targets

ProgramCompanyFurthest phaseStudies
LidocaineruleKeenova Therapeuticsphase 463
Carbamazepinerulegrin-therapeutics-incphase 421
DronedaroneruleSanofiphase 418
chloroprocainerulesintetica-saphase 48
RiluzoleruleSanofiphase 46
PrilocaineruleHaisco Pharmaceutical Groupphase 42
CarticaineruleLaboratoires Theaphase 41
Ropivacainerulepainreform-ltdphase 317
QuinidineruleOtsukaphase 317
PhenytoinruleViatrisphase 310
rufinamideruleEisaiphase 37

Studies

All 33 GlaxoSmithKline leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02513654Bipolar Disorder · China1CompletedNov 11, 201516
NCT02100644Epilepsy · Japan4CompletedMay 11, 201533
NCT02064465Epilepsy · China1CompletedJul 8, 2014138
NCT01879423Epilepsy · China1CompletedJun 6, 201324
NCT01602510Bipolar Disorder · China3CompletedDec 2015265
NCT01431976Epilepsy · Japan, Korea, Republic of3CompletedFeb 201420
NCT01431963Epilepsy · Japan, Korea, Republic of3CompletedMar 201370
NCT01357902Epilepsy · Hong Kong1CompletedMay 23, 201124
NCT00723450Bipolar Disorder · United States3CompletedAug 2013301
NCT00627575Epilepsy · United States1CompletedSep 12, 2008119
NCT00605371Epilepsy · United States1CompletedMar 6, 2008209
NCT00579982Mood Disorders · United States3CompletedFeb 200897
NCT00566020Bipolar Disorder · Japan3CompletedOct 201092
NCT00550407Bipolar Disorder · Japan3CompletedOct 2009215
NCT00516139Epilepsy · United States3CompletedJul 2010122
NCT00449774Mental Disorders · United States1CompletedJun 19, 2007220
NCT00412191Epilepsy · Germany1CompletedApr 27, 2007180
NCT00395694Epilepsy · Japan3CompletedMar 1, 2009102
NCT00360126Bipolar Disorder · Australia4CompletedFeb 200711
NCT00355082Epilepsies, Partial · United States, Argentina, Chile and more3CompletedNov 2008226
NCT00264615Epilepsy · United States3CompletedJun 200645
NCT00224510Bipolar Disorder · Netherlands, Spain3CompletedSep 2006120
NCT00144872Seizures · United States1CompletedApr 22, 200654
NCT00113165Epilepsy · United States, Argentina, Brazil and more3CompletedJul 2007244
NCT00104416Epilepsy, Tonic-Clonic · United States, Argentina, Brazil and more3CompletedJul 2008153
NCT00086593Schizophrenia · United States, Canada, United Kingdom3CompletedJul 2005209
NCT00071747Schizophrenia · United States3Completed176
NCT00067938Bipolar Disorder · United States4CompletedAug 20041,200
NCT00056277Bipolar Disorder · United States3CompletedAug 1, 2005150
NCT00044278Epilepsy · United States, Argentina, Australia and more2CompletedJun 2006197
NCT00043914Epilepsy4CompletedJan 29, 200372
NCT00043901Epilepsy, Tonic-Clonic · United States, Argentina, Chile and more4CompletedNov 1, 2003141
NCT00043875Epilepsy · United States, Australia, Estonia and more2CompletedNov 2003177

How it is read

Names in the registry

  • “Lamotrigine”, 26 entries
  • “lamotrigine”, 12 entries
  • “Lamotrigine Tablets 25 mg”, 4 entries
  • “Lamictal”, 3 entries
  • “Lamotrigine 25 mg Chewable Tablets”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.